Non-invasive continuous blood pressure and haematocrit monitoring
Dengue Shock ClassificationAnd Prediction wEarable
D-SCAPE, a wearable biomedical device, was developed at the Centre for Bio-Inspired Technology (CBIT) at Imperial College London. This novel device is a product of prestigious Wellcome Trust flagship funding and is designed to provide crucial monitoring support for Low and Middle-Income Countries (LMICs) in managing dengue outbreaks. D-SCAPE serves as a practical solution to enhance dengue treatment and patient care in resource-limited settings.
What is the Problem?
Dengue Outbreaks
Dengue is a major threat to the global healthcare landscape, putting 3.9 billion people at risk every year. Close monitoring of dengue progression remains the cornerstone of disease management. Patient deterioration is usually unpredictable, requiring frequent examination and close monitoring of vital and laboratory parameters – heart rate, blood pressure and haematocrit. This however, is often infeasible in many resource-limited/prehospital settings especially during the dengue season when a 200-300% surge in admission volume can overwhelm the local healthcare system. Furthermore, the invasive nature of blood tests results in patient discomfort and complications..
Our Solution
Innovative Monitoring
Revolutionary technology allows simultaneous real-time tracking of blood pressure and haematocrit, outclassing competitors in non-invasive precision.
Affordable Precision
Breakthrough technology offers precise monitoring at a fraction of the cost, making healthcare accessible with a device priced at $200 compared to competitors’ $3250+.
Dengue Prognosis
Enhanced predictive tools aimed at improving patient outcomes and drastically reduce the likelihood of misdiagnosing Dengue, a real medical breakthrough.
Workload Relief
Reducing clinician workload, the innovative system allows healthcare professionals to efficiently manage multiple patients, improving overall healthcare delivery.
Cost-Efficient Healthcare
By significantly cutting device costs and saving on staff and capital expenses, healthcare costs are dramatically reduced, optimizing resource allocation.
Savings and Efficiency
Beyond cost savings, the technology improves efficiency, reallocating resources for better patient care and yielding a positive impact on healthcare systems.
Your Opinion Counts
Take Our Survey
Whether you are a patient or a clinician, we would love to hear from you. Your opinion counts and we hope you can provide your feedback.
Our Leadership
Meet Our Team
Yuting Xu
Entrepreneur Lead
